Announcement
26 May 2021
In May 2021, Bpifrance provided EUR 31 million (approx. USD 37.8 million) to the LinKinVax-Label VRI consortium for developing a COVID-19 booster vaccine.
Source
Number of interventions
1
1 certainly harmful
0 likely harmful
0 liberalising
1 in force
Implementation date
26 May 2021
Revocation date:
No revocation date
On 26 May 2021, Bpifrance announced the provision of EUR 31 million (approx. USD 37.8 million) financing to the LinKinVax-Label VRI consortium for the development of a booster vaccine against COVID-19...
See all
This state act is not part of any Thread yet.